Related Experiment Video
Updated: Aug 15, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
[Physiopathology of Raynaud phenomenon: current data]
1Service de médecine interne, hôpital Broussais, Paris, France.
The exact causes of Raynaud's phenomenon are still unknown. New research suggests imbalances in vasoconstrictive and vasodilating peptides may explain digital artery vasospasm, offering new therapeutic avenues.
Area of Science:
- Vascular Medicine
- Physiology
- Pharmacology
Background:
- Raynaud's phenomenon pathophysiology remains incompletely understood.
- Current theories focus on sympathetic nervous system overactivity or local digital artery dysfunction.
- Potential roles for alpha-2 adrenoreceptors and serotoninergic receptors are considered.
Purpose of the Study:
- To elucidate the underlying mechanisms of digital artery vasospasm in Raynaud's phenomenon.
- To explore the contribution of specific neurochemical factors to the condition.
- To identify potential targets for novel therapeutic interventions.
Main Methods:
- Review of existing literature on Raynaud's phenomenon.
- Analysis of proposed etiological theories.
- Investigation of the roles of adrenergic, serotoninergic, and peptide systems.
Main Results:
- Increased sympathetic nervous system activity and local vascular defects are primary hypotheses.
- Enhanced alpha-2 adrenoreceptor activity and serotoninergic receptor activation may contribute to vasospasm.
- Elevated endothelin-1 (vasoconstrictor) and reduced calcitonin gene-related peptide (vasodilator) levels are implicated.
Conclusions:
- Imbalances in vasoconstrictive (endothelin-1) and vasodilating (calcitonin gene-related peptide) peptides offer a promising framework for understanding Raynaud's vasospasm.
- These findings may pave the way for new therapeutic strategies targeting these peptide systems.
More Related Videos
Related Concept Videos
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

